
Preveta
Preveta
Series
Unknown
AI-powered care navigation and clinical analytics for Oncology, Urology, and GI
AI-powered care navigation and clinical analytics for Oncology, Urology, and GI
FOUNDED
FOUNDED
2018
2018
TOTAL FUNDING
TOTAL FUNDING
TOTAL FUNDING
$8.3M
$8.3M
LATEST STAGE
LATEST STAGE
Series A
Series A
2023
2023
HEADCOUNT
HEADCOUNT
11-50
11-50
PRODUCT OVERVIEW
Preveta's AI-powered platform turns complex EMR data into structured clinical workflows built on specialty-specific clinical pathways—such as for oncology, urology, and GI. It guides patient navigators through what actions to take, surfaces gaps in care, highlights candidates for second- and third-line therapies or clinical trials, and continuously cleanses and enriches data. The goal is improved early detection, better outcomes, and streamlined chronic care management operations.
NURSE FOUNDER
COMPANY INFO
INVESTORS
Lead
MaC Venture Capital
Bullpen Capital, Sovereign's Capital, TSVC
ACCELERATORS
PRODUCT OVERVIEW
Preveta's AI-powered platform turns complex EMR data into structured clinical workflows built on specialty-specific clinical pathways—such as for oncology, urology, and GI. It guides patient navigators through what actions to take, surfaces gaps in care, highlights candidates for second- and third-line therapies or clinical trials, and continuously cleanses and enriches data. The goal is improved early detection, better outcomes, and streamlined chronic care management operations.
FUNDING TIMELINE
Funding timeline here
Funding timeline here
IN THE NEWS
NURSE FOUNDER
COMPANY INFO